+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Clinical Trials Market by Design (Interventional Study, Observational Study), Phase (Phase I, Phase II, Phase III), Indication - Forecast 2024-2030- Product Image
Global Clinical Trials Market by Design (Interventional Study, Observational Study), Phase (Phase I, Phase II, Phase III), Indication - Forecast 2024-2030- Product Image
Sale

Global Clinical Trials Market by Design (Interventional Study, Observational Study), Phase (Phase I, Phase II, Phase III), Indication - Forecast 2024-2030

  • PDF Icon

    Report

  • 183 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5134269
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Clinical Trials Market size was estimated at USD 38.30 billion in 2023, USD 41.78 billion in 2024, and is expected to grow at a CAGR of 9.16% to reach USD 70.78 billion by 2030.

Clinical trials are research activities that study new tests and treatments and evaluate effects on human health outcomes. It allows people to participate in testing medical interventions, including drugs, cells, other biological products, surgical procedures, radiological procedures, devices, behavioral treatments, and preventive care. The increased focus on developing and commercializing generics and biologics due to concerns related to chronic and infectious diseases increases demand for clinical trials. The growing emphasis on drug development activities and rising research and development expenditure from the pharmaceutical and biotechnology industry enhances the demand for clinical trials. However, the significant cost associated with clinical trial activities and stringent government regulations slow down drug development and research activities. Companies are focusing on cutting a cost alongside providing innovative research methodologies. Moreover, the worldwide focus on drug development and shift towards patient-centric clinical trials alongside rapidly improving globalization of clinical trials and greater regulatory harmonization and transparency promote innovation and better patient health and welfare.

Regional Insights

The growing expansion of clinical trials in the Americas significantly improved due to the increasing need for cancer diagnostic and cardiovascular diseases. Many regulatory organizations, such as the United States Food and Drug Administration (FDA) and the National Health Surveillance Agency (ANVISA), establish regulatory frameworks for drug development to ensure the quality of clinical trials conducted. In developing countries such as Mexico, Argentina, and Brazil, governments are making considerable investments to encourage research and technological advancements to boost the development of medical & healthcare infrastructure. The Asia-Pacific region’s clinical trial market is growing rapidly due to its evolving pharmaceutical industry in some countries, including China, India, South Korea, Taiwan, Indonesia, and Vietnam. In recent years, the growing investments in biotechnology and pharmaceutical industries in Australia and New Zealand have shown significant growth in clinical trial activities due to their emerging economies. Europe has been considered a rampart place for the global clinical trial due to the presence of numerous pharmaceutical and biotechnology companies. The European Union (EU) has a well-established framework for conducting clinical trials across its member states that ensures the safety, efficacy, and quality of investigational medicinal products.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Clinical Trials Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Clinical Trials Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Clinical Trials Market, highlighting leading vendors and their innovative profiles. These include Accell Clinical Research, LLC, Atlant Clinical Ltd., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bristol-Myers Squibb Company, Charles River Laboratories International, Inc., Clinipace, Congenix LLP, Eli Lilly and Company, Icon PLC, Illumina, Inc, IQVIA Holdings, Inc., Labcorp, Merck KGaA, Novo Nordisk A/S, Parexel International Corporation, Pfizer Inc., ProPharma Group Holdings, LLC, Qiagen NV, Sartorius AG, SGS S.A., SIRO Clinpharm Private Limited, Syneos Health, Inc., Thermo Fisher Scientific Inc., and Wuxi AppTec Inc.

Market Segmentation & Coverage

This research report categorizes the Clinical Trials Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Design
    • Interventional Study
      • Adaptive Clinical Trial
      • Non-randomized Control Trial
      • Randomized Control Trial
    • Observational Study
      • Case Control Study
      • Cohort Study
      • Cross Sectional Study
      • Ecological Study
  • Phase
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
  • Indication
    • Autoimmune/Inflammation
    • Cardiovascular
    • CNS condition
    • Diabetes
    • Infectious Diseases
    • Obesity
    • Oncology
    • Pain management
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Clinical Trials Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Clinical Trials Market?
  3. What are the technology trends and regulatory frameworks in the Clinical Trials Market?
  4. What is the market share of the leading vendors in the Clinical Trials Market?
  5. Which modes and strategic moves are suitable for entering the Clinical Trials Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Clinical Trials Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of diseases and improved clinical trials due to CRO consolidation
5.1.1.2. Growing R&D expenditure of pharmaceutical and biopharmaceutical industry
5.1.1.3. Increased focus on the development and commercialization of generics and biologics
5.1.2. Restraints
5.1.2.1. Increased cost of drug development and lack of skilled clinical research professional
5.1.3. Opportunities
5.1.3.1. Increased focus on drug development and shift towards patient-centric clinical trials
5.1.3.2. Growing globalization of clinical trials and harmonization of regulations
5.1.4. Challenges
5.1.4.1. Stringent regulations for patient enrollment and cross-border logistics challenges
5.2. Market Segmentation Analysis
5.2.1. Design: Importance of interventional and observational clinical trial design to optimize assessment of treatment efficacy, risk, and safety
5.2.2. Phase: clinical trial phases in for monitoring drug metabolism and gathering initial data
5.2.3. Indication: Several indications suggesting suitable treatments and medications for chronic, cardiovascular, and other harmful diseases
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Clinical Trials Market, by Design
6.1. Introduction
6.2. Interventional Study
6.3.1. Adaptive Clinical Trial
6.3.2. Non-randomized Control Trial
6.3.3. Randomized Control Trial
6.3. Observational Study
6.4.1. Case Control Study
6.4.2. Cohort Study
6.4.3. Cross Sectional Study
6.4.4. Ecological Study
7. Clinical Trials Market, by Phase
7.1. Introduction
7.2. Phase I
7.3. Phase II
7.4. Phase III
7.5. Phase IV
8. Clinical Trials Market, by Indication
8.1. Introduction
8.2. Autoimmune/Inflammation
8.3. Cardiovascular
8.4. CNS condition
8.5. Diabetes
8.6. Infectious Diseases
8.7. Obesity
8.8. Oncology
8.9. Pain management
9. Americas Clinical Trials Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Clinical Trials Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Clinical Trials Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
12.3.1. Merger & Acquisition
12.3.1.1. Kohlberg Acquires Majority Stake in Worldwide Clinical Trials
12.3.2. Agreement, Collaboration, & Partnership
12.3.2.1. Alcanza and Reveles Partner to Expand Inclusive Clinical Research in Underrepresented Communities
12.3.3. New Product Launch & Enhancement
12.3.3.1. The Bristol Myers Squibb-Janssen Collaboration Launches Pivotal Phase 3 Librexia Clinical Trial Program Evaluating Milvexian, an Investigational Oral Factor XIa Inhibitor
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Accell Clinical Research, LLC
13.1.2. Atlant Clinical Ltd.
13.1.3. Becton, Dickinson and Company
13.1.4. Bio-Rad Laboratories, Inc.
13.1.5. Bristol-Myers Squibb Company
13.1.6. Charles River Laboratories International, Inc.
13.1.7. Clinipace
13.1.8. Congenix LLP
13.1.9. Eli Lilly and Company
13.1.10. Icon PLC
13.1.11. Illumina, Inc
13.1.12. IQVIA Holdings, Inc.
13.1.13. Labcorp
13.1.14. Merck KGaA
13.1.15. Novo Nordisk A/S
13.1.16. Parexel International Corporation
13.1.17. Pfizer Inc.
13.1.18. ProPharma Group Holdings, LLC
13.1.19. Qiagen NV
13.1.20. Sartorius AG
13.1.21. SGS S.A.
13.1.22. SIRO Clinpharm Private Limited
13.1.23. Syneos Health, Inc.
13.1.24. Thermo Fisher Scientific Inc.
13.1.25. Wuxi AppTec Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. CLINICAL TRIALS MARKET RESEARCH PROCESS
FIGURE 2. CLINICAL TRIALS MARKET SIZE, 2023 VS 2030
FIGURE 3. CLINICAL TRIALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CLINICAL TRIALS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. CLINICAL TRIALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CLINICAL TRIALS MARKET DYNAMICS
FIGURE 7. CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2023 VS 2030 (%)
FIGURE 8. CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. CLINICAL TRIALS MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
FIGURE 10. CLINICAL TRIALS MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 12. CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CLINICAL TRIALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES CLINICAL TRIALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. CLINICAL TRIALS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. CLINICAL TRIALS MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. CLINICAL TRIALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. CLINICAL TRIALS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CLINICAL TRIALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 6. CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 8. CLINICAL TRIALS MARKET SIZE, BY ADAPTIVE CLINICAL TRIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. CLINICAL TRIALS MARKET SIZE, BY NON-RANDOMIZED CONTROL TRIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. CLINICAL TRIALS MARKET SIZE, BY RANDOMIZED CONTROL TRIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 13. CLINICAL TRIALS MARKET SIZE, BY CASE CONTROL STUDY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. CLINICAL TRIALS MARKET SIZE, BY COHORT STUDY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. CLINICAL TRIALS MARKET SIZE, BY CROSS SECTIONAL STUDY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. CLINICAL TRIALS MARKET SIZE, BY ECOLOGICAL STUDY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 18. CLINICAL TRIALS MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. CLINICAL TRIALS MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. CLINICAL TRIALS MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. CLINICAL TRIALS MARKET SIZE, BY PHASE IV, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 23. CLINICAL TRIALS MARKET SIZE, BY AUTOIMMUNE/INFLAMMATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. CLINICAL TRIALS MARKET SIZE, BY CNS CONDITION, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. CLINICAL TRIALS MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. CLINICAL TRIALS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. CLINICAL TRIALS MARKET SIZE, BY OBESITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. CLINICAL TRIALS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 47. CANADA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 48. CANADA CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 49. CANADA CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 50. CANADA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 51. CANADA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 52. MEXICO CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 53. MEXICO CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 54. MEXICO CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 55. MEXICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 56. MEXICO CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES CLINICAL TRIALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 70. AUSTRALIA CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 71. AUSTRALIA CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 72. AUSTRALIA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 73. AUSTRALIA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 74. CHINA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 75. CHINA CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 76. CHINA CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 77. CHINA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 78. CHINA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 79. INDIA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 80. INDIA CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 81. INDIA CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 82. INDIA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 83. INDIA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 85. INDONESIA CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 86. INDONESIA CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 87. INDONESIA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 88. INDONESIA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 89. JAPAN CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 90. JAPAN CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 91. JAPAN CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 92. JAPAN CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 93. JAPAN CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 95. MALAYSIA CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 96. MALAYSIA CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 97. MALAYSIA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 98. MALAYSIA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 100. PHILIPPINES CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 101. PHILIPPINES CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 102. PHILIPPINES CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 103. PHILIPPINES CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 105. SINGAPORE CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 106. SINGAPORE CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 107. SINGAPORE CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 108. SINGAPORE CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 110. SOUTH KOREA CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 111. SOUTH KOREA CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 112. SOUTH KOREA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 113. SOUTH KOREA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 115. TAIWAN CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 116. TAIWAN CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 117. TAIWAN CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 118. TAIWAN CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 119. THAILAND CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 120. THAILAND CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 121. THAILAND CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 122. THAILAND CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 123. THAILAND CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 125. VIETNAM CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 126. VIETNAM CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 127. VIETNAM CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 128. VIETNAM CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 135. DENMARK CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 136. DENMARK CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 137. DENMARK CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 138. DENMARK CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 139. DENMARK CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 140. EGYPT CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 141. EGYPT CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 142. EGYPT CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 143. EGYPT CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 144. EGYPT CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 145. FINLAND CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 146. FINLAND CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 147. FINLAND CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 148. FINLAND CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 149. FINLAND CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 150. FRANCE CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 151. FRANCE CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 152. FRANCE CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 153. FRANCE CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 154. FRANCE CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 155. GERMANY CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 156. GERMANY CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 157. GERMANY CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 158. GERMANY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 159. GERMANY CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 161. ISRAEL CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 162. ISRAEL CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 163. ISRAEL CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 164. ISRAEL CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 165. ITALY CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 166. ITALY CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 167. ITALY CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 168. ITALY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 169. ITALY CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 171. NETHERLANDS CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 172. NETHERLANDS CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 173. NETHERLANDS CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 174. NETHERLANDS CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 176. NIGERIA CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 177. NIGERIA CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 178. NIGERIA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 179. NIGERIA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 180. NORWAY CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 181. NORWAY CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 182. NORWAY CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 183. NORWAY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 184. NORWAY CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 185. POLAND CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 186. POLAND CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 187. POLAND CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 188. POLAND CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 189. POLAND CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 190. QATAR CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 191. QATAR CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 192. QATAR CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 193. QATAR CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 194. QATAR CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 199. RUSSIA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 202. SAUDI ARABIA CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 204. SAUDI ARABIA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 208. SOUTH AFRICA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 210. SPAIN CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 211. SPAIN CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 212. SPAIN CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 213. SPAIN CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 214. SPAIN CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 216. SWEDEN CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 217. SWEDEN CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 218. SWEDEN CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 219. SWEDEN CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 221. SWITZERLAND CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 222. SWITZERLAND CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 223. SWITZERLAND CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 224. SWITZERLAND CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 225. TURKEY CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 226. TURKEY CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 227. TURKEY CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 228. TURKEY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 229. TURKEY CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2030 (USD MILLION)
TABLE 238. UNITED KINGDOM CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 240. CLINICAL TRIALS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 241. CLINICAL TRIALS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 242. CLINICAL TRIALS MARKET LICENSE & PRICING

Companies Mentioned

  • Accell Clinical Research, LLC
  • Atlant Clinical Ltd.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bristol-Myers Squibb Company
  • Charles River Laboratories International, Inc.
  • Clinipace
  • Congenix LLP
  • Eli Lilly and Company
  • Icon PLC
  • Illumina, Inc
  • IQVIA Holdings, Inc.
  • Labcorp
  • Merck KGaA
  • Novo Nordisk A/S
  • Parexel International Corporation
  • Pfizer Inc.
  • ProPharma Group Holdings, LLC
  • Qiagen NV
  • Sartorius AG
  • SGS S.A.
  • SIRO Clinpharm Private Limited
  • Syneos Health, Inc.
  • Thermo Fisher Scientific Inc.
  • Wuxi AppTec Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages183
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 41.78 Billion
Forecasted Market Value ( USD ) by 2030 $ 70.78 Billion
Compound Annual Growth Rate9.1%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Global Omics-Based Clinical Trials Market by Phase (Phase I, Phase II, Phase III), Study Design (Expanded Access Studies, Interventional Studies, Observational Studies), Indication - Forecast 2024-2030 - Product Image

Global Omics-Based Clinical Trials Market by Phase (Phase I, Phase II, Phase III), Study Design (Expanded Access Studies, Interventional Studies, Observational Studies), Indication - Forecast 2024-2030

  • Report
  • 189 Pages
  • Global
From
Global Immuno-oncology Clinical Trials Market by Design (Expanded Access Trials, Interventional Trials, Observational Trials), Phase (Phase I, Phase II, Phase III), Indication - Forecast 2024-2030 - Product Image

Global Immuno-oncology Clinical Trials Market by Design (Expanded Access Trials, Interventional Trials, Observational Trials), Phase (Phase I, Phase II, Phase III), Indication - Forecast 2024-2030

  • Report
  • 197 Pages
  • Global
From
Virtual Clinical Trials Market Size, Share & Trends Analysis Report By Study Design (Interventional, Observational, Expanded Access), By Indication (Oncology, Cardiovascular Disease), By Phase, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Virtual Clinical Trials Market Size, Share & Trends Analysis Report By Study Design (Interventional, Observational, Expanded Access), By Indication (Oncology, Cardiovascular Disease), By Phase, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 133 Pages
  • Global
From
Mental Health Clinical Trials Market Size, Share & Trends Analysis Report By Phase, By Study Design (Interventional, Observational), By Sponsor, By Disorder (Anxiety Disorders, Depression, Schizophrenia), By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Mental Health Clinical Trials Market Size, Share & Trends Analysis Report By Phase, By Study Design (Interventional, Observational), By Sponsor, By Disorder (Anxiety Disorders, Depression, Schizophrenia), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 100 Pages
  • Global
From
Clinical Trials Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis - Product Image

Clinical Trials Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis

  • Report
  • 220 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.